Eagle pharmaceuticals revenue
WebMar 7, 2024 · Eagle Pharmaceuticals, which belongs to the Zacks Medical - Products industry, posted revenues of $42.32 million for the quarter ended December 2024, … WebMar 13, 2024 · Eagle Pharmaceuticals (EGRX) came out with quarterly earnings of $1.10 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.85 per share a year ago.
Eagle pharmaceuticals revenue
Did you know?
WebApr 14, 2024 · The company has a market cap of $5.22 billion, a P/E ratio of 12.51 and a beta of 1.31. Eagle Materials ( NYSE:EXP - Get Rating) last posted its quarterly earnings results on Thursday, January 26th. The construction company reported $3.20 earnings per share for the quarter, topping the consensus estimate of $3.19 by $0.01.
WebAug 9, 2024 · EAGLE PHARMACEUTICALS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (In thousands, except share amounts) June 30, 2024: December 31, 2024: ASSETS: Current assets: Cash and cash equivalents $ WebMar 27, 2024 · Eagle Pharmaceuticals's annual revenues are $10-$50 million (see exact revenue data) and has 100-500 employees. It is classified as operating in the Medicinal …
WebDec 31, 2024 · Find out how Eagle Pharmaceuticals, Inc. (EGRX) is performing against its competitors. Compare financial ratios of 10,000 largest U.S. public companies with industry averages. ... 2834 - Pharmaceutical Preparations: Revenue in 2024: $171,546 thousand (ranked #190 out of 638 companies in the industry) Assets as of 12/31/2024 : $253,732 ... WebRevenue in 2024 (TTM): $0.31 B. According to Eagle Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $0.31 B . In 2024 the company made a …
WebMar 2, 2024 · Eagle Pharmaceuticals, which belongs to the Zacks Medical - Products industry, posted revenues of $49.92 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 0.32%.
WebMar 13, 2024 · Fourth Quarter 2024. Total revenue for Q4 2024 was $60.7 million, compared to $42.3 million in Q4 2024. Q4 2024 net income was $8.2 million, or $0.63 per basic and $0.62 per diluted share, compared to net loss of $ (6.2) million, or $ (0.48) per … how the ice age happenedWebMar 13, 2024 · Eagle Pharmaceuticals press release ( NASDAQ: EGRX ): Q4 Non-GAAP EPS of $1.11 beats by $0.28. Revenue of $60.7M (+43.4% Y/Y) misses by $3.56M. Q4 … metal detecting california beachesWebMar 27, 2024 · Eagle Pharmaceuticals's annual revenues are $10-$50 million (see exact revenue data) and has 100-500 employees. It is classified as operating in the Medicinal & Botanical Manufacturing industry. Eagle Pharmaceuticals's Annual Report & Profile shows critical firmographic facts: What is the company's size? ... how the hyperlink changed everythingWebMar 13, 2024 · Eagle Pharmaceuticals (EGRX) Beats Q4 Earnings and Revenue Estimates Zacks Mar. 13, 2024, 08:05 AM Eagle Pharmaceuticals (EGRX) came out with quarterly earnings of $1.10 per share,... metal detecting carhamptonWebMar 13, 2024 · Eagle Pharmaceuticals , which belongs to the Zacks Medical - Products industry, posted revenues of $60.7 million for the quarter ended December 2024, … metal detecting cape cod beachesWebEagle Pharmaceutical Corp Revenue $246.2 M Employees 102 Primary Industries Pharmaceuticals Manufacturing Funding History Eagle Pharmaceuticals raised a total of $200.3 M in funding over 2 rounds, and is a public traded company. CEO Scott Tarriff Stock Symbol NASDAQ: EGRX Eagle Pharmaceuticals Executive Team & Key Decision Makers how the hypothalamus stimulate the pituitaryWebApr 14, 2024 · Position: HEALTH INFORMATION TECHNOLOGY - ENTRY LEVEL /RECENT GRAD Location: Ashburn Leading edge Revenue Cycle Management … metal detecting clubs in suffolk